Stem cell op could bring back sight for millions: AMD Breakthrough

via www.cumc.columbia.edu
via www.cumc.columbia.edu

A revolutionary technique that promises to restore the sight of millions has been carried out for the first time worldwide in a British hospital.

Taking as little as 45 minutes, the procedure offers hope to those with age-related macular degeneration, the leading cause of blindness in adults globally.

It affects more than 600,000 adults in the UK, blighting the lives of a quarter of the over-60s.

In the breakthrough developed at University College London, doctors inserted a patch of stem cells into the retina of a woman who has lost her central vision.

They hope the procedure, carried out at Moorfields Eye Hospital in the capital, will restore the 60-year-old’s sight but will not know the outcome until December.

However, doctors said she suffered no complications and her eye is recovering well from the procedure.

This first operation has begun a clinical trial involving ten patients. If successful, the technique could be available on the NHS within two-and-a-half years.

The procedure, which has attracted the support of medical giant Pfizer, is carried out under local anaesthetic. It involves taking a single embryonic stem cell and growing it into a 6mm patch of 100,000 retinal pigment cells.

That patch is then rolled into a thin tube, which is injected through a tiny slit in the eye.

Once unfurled, it is placed behind the retina where scientists hope it will replace the faulty cells.

The operation is a milestone in the London Project to Cure Blindness established ten years ago with the aim of curing vision loss in patients with age-related macular degeneration.

The first step has been carried out on the wet form of the condition when a patient bleeds at the back of the eye. But scientists are confident it could also be used for the more common dry AMD, which affects 85 per cent of British sufferers.

Read more: Stem cell op could bring back sight for millions: UK breakthrough for age-related illness may reach NHS in two-and-a-half years

See Also

 

The Latest on: Age-related macular degeneration

[google_news title=”” keyword=”age-related macular degeneration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]

via Google News

 

The Latest on: Age-related macular degeneration
  • Cataract Surgery in Patients With Diabetes and Age-Related Macular Degeneration
    on May 23, 2024 at 5:01 pm

    The timing of surgery is critical as an unclear view of the retina may delay possible treatment for neovascular age-related macular degeneration (e.g., with photodynamic therapy). Patients should ...

  • Age related macular degeneration: What to ask your doctor
    on May 22, 2024 at 5:00 pm

    We've tried to contact you several times as we haven't been able to take payment. You must update your payment details via My Account or by clicking update payment details to keep your ...

  • FDA Approves Biosimilars for Macular Degeneration Treatment
    on May 22, 2024 at 7:56 am

    The FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work the same way as Eylea which prevents abnormal blood vessel growth in the eye and helps preserve ...

  • Age-Related Macular Degeneration: Putting a Hole in Our World
    on May 10, 2024 at 12:04 pm

    Estimates show that by 2040, age-related macular degeneration may affect nearly 300 million people worldwide. And we are very limited in our ability to treat or prevent it. Here's what to know.

  • Wet vs. Dry Age-Related Macular Degeneration (AMD)
    on May 9, 2024 at 8:29 pm

    Wet macular degeneration always begins with dry AMD, says Mayo Clinic. Both dry and wet age-related macular degeneration (AMD) involve changes to the macula, part of the retina in your eye.

  • Macular Degeneration
    on May 5, 2024 at 5:00 pm

    This is also called age-related macular degeneration (AMD), as the major risk factor for this is aging. It is an eye disorder characterized by a number of conditions negatively affecting the macula.

  • Neovascular Age-related Macular Degeneration and anti-VEGF Nonresponders
    on April 25, 2024 at 5:00 pm

    Expert Rev Ophthalmol. 2010;5(1):35-41. Anti-VEGF therapy is effective for neovascular age-related macular degeneration (AMD); however, there are patients who fail to respond to monotherapy alone.

  • Age-Related Macular Degeneration
    on March 11, 2024 at 1:00 am

    For more information on Age-Related Macular Degeneration go to the NHS website. If you've had a diagnosis, in addition to support from your specialist, you may find it useful to use support groups ...

  • What Is Wet Age-Related Macular Degeneration?
    on February 25, 2024 at 12:34 pm

    To help detect or confirm a diagnosis of wet AMD, your doctor may perform other tests and procedures, including the following: Both dry and wet age-related macular degeneration (AMD) involve ...

via  Bing News

 

What's Your Reaction?
Don't Like it!
0
I Like it!
0
Scroll To Top